Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Phase I/II clinical testing begins of VLTS-589 for peripheral arterial disease

June 15, 2001

Diovan sNDA for heart failure receives priority review by FDA

June 15, 2001

FDA grants CytRx's Flocor fast track status

June 15, 2001

Diarylamides from Japan Energy inhibit PDGF-induced cell proliferation

June 12, 2001

Gene therapy as alternative to transplantation in hereditary dilated cardiomyopathy

June 12, 2001

Amelioration of RV hypertrophy by endothelin antagonist related to normalization of calcium handling

June 12, 2001

Ranolazine improves LV function in heart failure by optimizing myocardial efficiency

June 12, 2001

Potent cGMP-specific PDE inhibitors and their potential uses disclosed by Takeda

June 11, 2001

Use of radolmidine for preventing hypotension and shock

June 6, 2001

BMS studies new Na+/H+ exchange inhibitors with antianginal, cardioprotective properties

June 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...